In this live, interactive training session, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster. You will learn how to: • Differentiate between clinically significant variants and variants of unknown significance (VUS) • Use batch search vs. advanced search, including their differences […]
Discovering new genes implicated in hereditary diseases or cancer progression is challenging yet advancing rapidly due to the increase in next-generation sequencing (NGS) cohort data. These data analyses produce insights into associations between gene variants and diseases and the biological mechanisms of these gene variants. By combining QIAGEN CLC Genomics Workbench, QCIIT and QIAGEN IPA, […]
Large dataset analysis and exploring the knowledge base using QIAGEN Ingenuity Pathway Analysis (IPA) Join us for a 120-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to: • Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA • Understand the different […]
In this 60-minute session, the trainer will go over how to effectively utilize a relationship database for below applications. In this case, QIAGEN Biomedical Knowledgebase (Biomedical KB – a database containing high-quality relationship literature findings, the same database backing Ingenuity Pathway Analysis/IPA) will be used, but learning can possibly be applied to similar databases as […]
AI has begun to transform and accelerate every step of the drug development lifecycle from target identification to drug discovery and clinical trial design. However, the rapid development and adoption of AI platforms come with its own set of challenges regarding data quality, data privacy, and an evolving regulatory landscape. Panelists in this webinar will […]
Next-generation sequencing (NGS) has rapidly gained popularity as a diagnostic testing approach due to its unparalleled ability to comprehensively analyze genetic information with high throughput and precision. However, decentralized and small labs face significant hurdles when it comes to adopting NGS testing. From high upfront costs associated with acquiring the necessary equipment, to the complexity […]
In the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, the Ingenuity team with QIAGEN has curated these nodes and relationships. Our QIAGEN Biomedical KB-HD make these data available for consumption outside of Ingenuity Pathway Analysis. In this talk, we will: […]
In this live, interactive training session, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster. You will learn how to: • Differentiate between clinically significant variants and variants of unknown significance (VUS) • Use batch search vs. advanced search, including their differences […]
In this live, interactive training session, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster. You will learn how to: • Differentiate between clinically significant variants and variants of unknown significance (VUS) • Use batch search vs. advanced search, including their differences […]
By connecting diverse entities and relationships, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the […]
By connecting diverse entities and relationships, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the […]
QIAGEN Ingenuity Pathway Analysis (IPA) is more than just an analysis program; it can also help you write grants and publications. IPA provides biological insights backed by expert-curated findings and thousands of pre-analyzed multiomics datasets. You can search for existing knowledge on molecules of interest, build networks and review results from public studies. Or you […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
